Failure to obtain cultures and sensitivities before antibiotic treatment for recurrent UTI episodes
Summary
The facility failed to obtain cultures and sensitivities before administering antibiotics for multiple urinary tract infection episodes for one resident. The resident had diagnoses including morbid obesity, type 2 diabetes mellitus with diabetic neuropathy, dysuria, and lower abdominal pain, and was assessed as cognitively intact but highly dependent for many activities of daily living, with total dependence for toileting and frequent or total incontinence. Review of the record showed treatment with Levaquin, Nitrofurantoin, and Ciprofloxacin for separate UTI episodes, along with a urine culture order for dysuria and lower abdominal pain and a follow-up urology appointment. For the March episode, the resident’s UA showed abnormalities suggestive of a possible UTI, including turbid clarity, positive leukocyte esterase, elevated WBCs, mildly elevated RBCs, and few bacteria, but the reflex urine culture grew 10,000 to 50,000 colonies/mL of Gram-negative bacilli in three kinds and was interpreted by the lab as suggestive of contamination. No sensitivity testing was performed to identify a specific pathogen to guide antibiotic therapy, and the resident was started on Levaquin. For the July episode, a UA with reflex culture was ordered for dysuria and lower abdominal pain but was not obtained, and the record showed the UA result as autocancelled by the system. The resident was given Pyridium during that period. Later, the resident requested hospital evaluation for bladder incontinence and was found to have an active UTI, after which Ciprofloxacin was ordered upon return. The DON confirmed that no culture and sensitivity was completed for the March episode and stated that the July UA may have been intended to be completed later, but the resident’s symptoms improved after Pyridium and follow-up testing was not completed. The Manager of Clinical Services stated that all antibiotics administered were broad-spectrum and that no culture or sensitivity testing was obtained for any of the broad-spectrum antibiotic courses.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.